Nima Sharifi, Mahaz Kayani, Laura Murphy, Robert Diaz, Emily Grist, Zsofia Kote-Jarai, Ros A. Eeles, Gianmarco Leone, Noel W Clarke, Mahesh K. B. Parmar, Louise C. Brown, Nicholas David James, Gerhardt Attard. "HSD3B1 and overall survival (OS) in high-risk non-metastatic (M0) and metastatic (M1) prostate cancer starting androgen deprivation therapy (ADT) in the enzalutamide (ENZ) and abiraterone acetate plus prednisolone (AAP) STAMPEDE phase 3 trial.." Journal of Clinical Oncology, 2025. doi:10.1200/jco.2025.43.5_suppl.234